Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone

Shereen Elazzazy1 Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, QatarCorrespondence[email protected]

Saad S Eziada2 Oncology Hematology Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

Manal Zaidan1 Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Richard M. Turner, Vanessa Fontana, Richard FitzGerald, Andrew P. Morris & Munir Pirmohamed. (2020) Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention. British Journal of Clinical Pharmacology 86:1, pages 62-74.
Crossref

Ana Anoveros‐Barrera, Amritpal S. Bhullar, Cynthia Stretch, Nina Esfandiari, Abha R. Dunichand‐Hoedl, Karen J.B. Martins, David Bigam, Rachel G. Khadaroo, Todd McMullen, Oliver F. Bathe, Sambasivarao Damaraju, Richard J. Skipworth, Charles T. Putman, Vickie E. Baracos & Vera C. Mazurak. (2019) Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients. Journal of Cachexia, Sarcopenia and Muscle 10:6, pages 1356-1377.
Crossref

Claire S Nunn. (2017) Focus on dexamethasone: Malignancy and palliative care. Nurse Prescribing 15:11, pages 556-562.
Crossref

. (2017) Does the use of proton pump inhibitors increase the risk of rhabdomyolysis?. Drugs & Therapy Perspectives 33:10, pages 484-486.
Crossref

Alice Capogrosso Sansone, Irma Convertino, Maria Teresa Galiulo, Stefano Salvadori, Stefania Pieroni, Tamara Knezevic, Stefania Mantarro, Alessandra Marino, Manfred Hauben, Corrado Blandizzi & Marco Tuccori. (2017) Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database. Drug Safety 40:10, pages 895-909.
Crossref

Scott J. Duncan & Colin W. Howden. (2016) Proton Pump Inhibitors and Risk of Rhabdomyolysis. Drug Safety 40:1, pages 61-64.
Crossref

G.B. John Mancini, A. Yashar Tashakkor, Steven Baker, Jean Bergeron, David Fitchett, Jiri Frohlich, Jacques Genest, Milan Gupta, Robert A. Hegele, Dominic S. Ng, Glen J. Pearson & Janet Pope. (2013) Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update. Canadian Journal of Cardiology 29:12, pages 1553-1568.
Crossref

Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date